SweetValueLab
Write for us

The Kroger Co. — Wall Street Analyst Estimates & Price Targets

KR
NYSEConsumer DefensiveGrocery StoresCIK 0000056873thekrogerco.comAbout KR
Last close · Oct 16, 202663.63+0.92 (+1.47%)
Market cap$37.6B

7 firms' latest targets, last 90 days: median $72.00 ($66.00–$80.00), 13% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$60.0$70.0$80.0NovJan 2026MarMayJulSep2025-11-19 · Guggenheim: $78.02025-11-26 · Coker Palmer: $73.02025-12-01 · Telsey Advisory Group: $82.02025-12-04 · Wells Fargo: $70.02025-12-05 · Telsey Advisory Group: $80.02025-12-05 · Evercore ISI: $77.02025-12-05 · UBS: $70.02025-12-08 · Morgan Stanley: $72.02026-01-08 · Deutsche Bank: $75.02026-01-08 · Barclays: $68.02026-01-15 · Morgan Stanley: $67.02026-03-05 · Jefferies: $82.02026-03-05 · Morgan Stanley: $73.02026-03-05 · Wolfe Research: $75.02026-03-05 · BMO Capital: $70.02026-03-09 · Evercore ISI: $83.02026-06-03 · Jefferies: $80.02026-06-11 · Coker Palmer: $70.02026-06-19 · Goldman Sachs: $82.02026-06-22 · Telsey Advisory Group: $78.02026-06-22 · UBS: $63.02026-06-22 · Guggenheim: $71.02026-06-22 · Wells Fargo: $58.02026-06-22 · Barclays: $61.02026-07-07 · Evercore ISI: $78.02026-09-09 · Deutsche Bank: $68.02026-09-14 · Telsey Advisory Group: $75.02026-09-14 · Guggenheim: $66.02026-09-14 · Roth Capital: $73.02026-09-14 · Evercore ISI: $70.02026-09-29 · Melius Research: $80.02026-10-07 · BNP Paribas Exane: $72.0
$60.0$70.0$80.0NovFebMayAug

Each firm's latest target

last 90 days · 7 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-07BNP Paribas Exane$72.00——+23%+13%
2026-09-29Melius Research$80.00——+34%+26%
2026-09-14Telsey Advisory Group$75.00$78.00▼ 4%+23%+18%
2026-09-14Guggenheim$66.00$71.00▼ 7%+9%+4%
2026-09-14Roth Capital$73.00——+25%+15%
2026-09-14Evercore ISI$70.00$78.00▼ 10%+20%+10%
2026-09-09Deutsche Bank$68.00$75.00▼ 9%+19%+7%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2024reported$150.0B+1%$2.96-3%est. $149.8B+0%est. $4.5614
2025reported$147.1B-2%$3.67+24%est. $147.5B+0%est. $4.4615
2026reported$147.6B+0%$1.54-58%est. $148.0B+0%est. $4.8015
2027$150.8B+2%$5.19+8%$149.5B–$152.0B$5.15–$5.2517
2028$152.7B+1%$5.51+6%$150.1B–$157.7B$5.30–$5.9616
2029$155.6B+2%$5.85+6%$152.3B–$166.2B$5.35–$6.3313
2030$161.8B+4%$6.36+9%$158.8B–$166.5B$6.21–$6.606
2031$163.8B+1%$6.31-1%$160.8B–$168.6B$6.16–$6.558
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.